Cargando…
New screening approach for Alzheimer’s disease risk assessment from urine lipid peroxidation compounds
Alzheimer Disease (AD) standard biological diagnosis is based on expensive or invasive procedures. Recent research has focused on some molecular mechanisms involved since early AD stages, such as lipid peroxidation. Therefore, a non-invasive screening approach based on new lipid peroxidation compoun...
Autores principales: | Peña-Bautista, Carmen, Vigor, Claire, Galano, Jean-Marie, Oger, Camille, Durand, Thierry, Ferrer, Inés, Cuevas, Ana, López-Cuevas, Rogelio, Baquero, Miguel, López-Nogueroles, Marina, Vento, Máximo, Hervás-Marín, David, García-Blanco, Ana, Cháfer-Pericás, Consuelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775072/ https://www.ncbi.nlm.nih.gov/pubmed/31578419 http://dx.doi.org/10.1038/s41598-019-50837-2 |
Ejemplares similares
-
Clinical Utility of Plasma Lipid Peroxidation Biomarkers in Alzheimer’s Disease Differential Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2020) -
Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2021) -
Isoprostanoids Levels in Cerebrospinal Fluid Do Not Reflect Alzheimer’s Disease
por: Peña-Bautista, Carmen, et al.
Publicado: (2020) -
Oxidative Damage of DNA as Early Marker of Alzheimer’s Disease
por: Peña-Bautista, Carmen, et al.
Publicado: (2019) -
Early neurotransmission impairment in non-invasive Alzheimer Disease detection
por: Peña-Bautista, Carmen, et al.
Publicado: (2020)